DuPont de Nemours Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Los beneficios de DuPont de Nemours han disminuido a una tasa media anual de -18.9%, mientras que en la industria Chemicals los beneficios disminuyeron en un 3.6% anualmente. Los ingresos han ido disminuyendo a una tasa media de 16.4% al año. La rentabilidad financiera de DuPont de Nemours es de 1.2%, y sus márgenes netos son de 1.9%.
Información clave
-18.88%
Tasa de crecimiento de los beneficios
-17.03%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.93% |
| Tasa de crecimiento de los ingresos | -16.43% |
| Rentabilidad financiera | 1.18% |
| Margen neto | 1.91% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Jun 27
DD: Reverse Stock Split And 2026 Guidance Will Support Further Upside
Analysts have lifted their DuPont de Nemours fair value estimate from about $57.07 to roughly $172.07, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E that modestly adjust their valuation framework. What’s in the News for DuPont de Nemours DuPont de Nemours is executing a 1 for 3 reverse stock split of its common stock effective June 24, 2026, as highlighted in recent coverage on upcoming reverse splits for DuPont and Honeywell (source: What Honeywell’s and DuPont’s Coming Reverse Stock Splits Mean for Investors).Artículo de análisis • Jun 19
DuPont De Nemours (DD) Stock Could Be 16.4% Undervalued Based On Analyst Targets
DuPont de Nemours (DD) is back in focus after investors revisited the stock following its recent share price moves, prompting a closer look at how its returns line up with current fundamentals. See our latest analysis for DuPont de Nemours. At a share price of $47.71, DuPont de Nemours has seen its short term momentum cool slightly with a 1 day share price return that declined 0.50%. However, its 90 day share price return of 12.42% and 1 year total shareholder return of 73.77% point to...Actualización de narrativa • Jun 13
DD: Water Infrastructure Contracts And 2026 Guidance Will Support Further Upside
Analysts have nudged their average price target for DuPont de Nemours higher from $56.13 to about $57.07, reflecting updated assumptions for slightly different discount rates, revenue growth, profit margins, and future P/E levels. What's in the News DuPont's MemCor MBR system was selected for a major upgrade at the Riverstone Water Resource Recovery Facility in Sydney, supporting higher wastewater treatment capacity and long term environmental protection in a fast growing region.
Actualización de narrativa • May 30
DD: Guidance Reaffirmation And Buybacks Will Support Future Upside Potential
Analysts have nudged their price target for DuPont de Nemours slightly higher to $64.00, citing updated assumptions for revenue growth, profit margins and future P/E that refine rather than overhaul their outlook on the stock. What's in the News Shareholders approved an amendment to the Certificate of Incorporation to allow a reverse stock split between 1-for-2 and 1-for-4, along with a corresponding reduction in authorized common shares at the May 21, 2026 AGM (Changes in Company Bylaws/Rules).Seeking Alpha • May 27
I See A Better DuPont, Not A Bargain
Summary DuPont de Nemours, Inc. is a leading science and materials company supplying specialized products to manufacturers, not direct consumers. DD recently sold its Aramids division, including Kevlar and Nomex, for $1.8 billion, streamlining its portfolio. AI and data center demand are driving significant growth in DD's microelectronics segment, making it a core business focus. After years of underperformance, DD shares have begun to outperform the S&P 500, supported by a reverse split and reaffirmed 2026 guidance. Read the full article on Seeking AlphaActualización de narrativa • May 07
DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside
Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.Actualización de narrativa • Apr 23
DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside
Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Actualización de narrativa • Apr 08
DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook
Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.Actualización de narrativa • Mar 24
DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside
Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.Actualización de narrativa • Mar 09
DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside
Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.Actualización de narrativa • Feb 23
DD: New Guidance And Product Pipeline Will Support Future Upside
Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.Artículo de análisis • Feb 17
There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings
The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...Actualización de narrativa • Feb 09
DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside
Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).Actualización de narrativa • Jan 26
DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity
Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).Actualización de narrativa • Jan 12
DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook
Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).Actualización de narrativa • Dec 27
DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity
Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.Actualización de narrativa • Dec 13
DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook
Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.Actualización de narrativa • Nov 29
DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground
Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.Actualización de narrativa • Nov 15
DD: Future Share Buybacks Will Unlock Value Amid Uncertainty
Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.Artículo de análisis • Nov 09
DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year
DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...Actualización de narrativa • Nov 01
DD: Qnity Separation And Water Solutions Will Drive Outperformance
Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.Actualización de narrativa • Oct 17
Electronics, Healthcare And Water Will Drive Future Success
Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.Actualización de narrativa • Sep 24
Electronics, Healthcare And Water Will Drive Future Success
Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.Actualización de narrativa • Sep 04
Electronics, Healthcare And Water Will Drive Future Success
As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.Artículo de análisis • Jul 23
Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero DuPont de Nemours. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 6,918 | 132 | 1,037 | 190 |
| 31 Dec 25 | 6,849 | 57 | 1,014 | 193 |
| 30 Sep 25 | 5,722 | 479 | 836 | 150 |
| 30 Jun 25 | 5,512 | 630 | 813 | 137 |
| 31 Mar 25 | 5,400 | -234 | 822 | 128 |
| 31 Dec 24 | 6,719 | -131 | 967 | 203 |
| 30 Sep 24 | 11,161 | 421 | 1,474 | 498 |
| 30 Jun 24 | 11,357 | 260 | 1,472 | 499 |
| 31 Mar 24 | 11,981 | 404 | 1,452 | 506 |
| 31 Dec 23 | 6,614 | -101 | 904 | 192 |
| 30 Sep 23 | 12,274 | 895 | 1,394 | 503 |
| 30 Jun 23 | 12,533 | 963 | 1,380 | 504 |
| 31 Mar 23 | 12,761 | 1,065 | 1,399 | 520 |
| 31 Dec 22 | 13,017 | 1,012 | 1,439 | 536 |
| 30 Sep 22 | 13,159 | 1,064 | 1,481 | 561 |
| 30 Jun 22 | 13,041 | 960 | 1,556 | 569 |
| 31 Mar 22 | 12,823 | 989 | 1,565 | 561 |
| 31 Dec 21 | 12,566 | 1,159 | 1,572 | 557 |
| 30 Sep 21 | 13,070 | 1,453 | 1,596 | 568 |
| 30 Jun 21 | 13,500 | 1,286 | 1,571 | 571 |
| 31 Mar 21 | 13,685 | -1,496 | 1,589 | 591 |
| 31 Dec 20 | 11,128 | -1,377 | 1,480 | 565 |
| 30 Sep 20 | 15,792 | -2,694 | 1,912 | 697 |
| 30 Jun 20 | 17,589 | -2,406 | 2,137 | 782 |
| 31 Mar 20 | 19,768 | -1,147 | 2,355 | 861 |
| 31 Dec 19 | 15,436 | -227 | 1,985 | 689 |
| 30 Sep 19 | 21,765 | -620 | 2,663 | 986 |
| 30 Jun 19 | 22,022 | -896 | 2,746 | 1,025 |
| 31 Mar 19 | 22,411 | 230 | 2,862 | 1,063 |
| 31 Dec 18 | 22,594 | 233 | 2,932 | 1,070 |
| 30 Sep 18 | 37,203 | -1,249 | 4,387 | 1,594 |
| 30 Jun 18 | 46,874 | -809 | 4,647 | 1,858 |
| 31 Mar 18 | 54,851 | 517 | 4,626 | 1,996 |
| 31 Dec 17 | 11,672 | 88 | 1,580 | 657 |
| 30 Sep 17 | 55,438 | 2,698 | 3,257 | 1,780 |
| 30 Jun 17 | 52,567 | 2,882 | 3,019 | 1,651 |
| 31 Mar 17 | 50,685 | 4,672 | 3,014 | 1,642 |
| 31 Dec 16 | 48,158 | 3,956 | 2,919 | 1,593 |
| 30 Sep 16 | 46,600 | 7,490 | 2,865 | 1,563 |
| 30 Jun 16 | 46,153 | 8,056 | 2,815 | 1,546 |
| 31 Mar 16 | 47,111 | 6,079 | 2,868 | 1,576 |
| 31 Dec 15 | 48,778 | 7,294 | 2,948 | 1,598 |
| 30 Sep 15 | 51,700 | 4,520 | 3,021 | 1,622 |
Ingresos de calidad: DD tiene una única gran pérdida de $416.0M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.
Margen de beneficios creciente: DD pasó a ser rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: DD ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de -18.9% al año.
Acelerando crecimiento: DD ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.
Beneficios vs. Industria: DD ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (0.1%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de DD (1.2%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/07/01 22:21 |
| Precio de las acciones al final del día | 2026/07/01 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
DuPont de Nemours, Inc. está cubierta por 35 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| William Selesky | Argus Research Company |
| Patrick Duffy Fischer | Barclays |
| Michael Leithead | Barclays |